Dataset - Cr3+-doped gamma-and beta-Gallium Oxide Nanoprobes for Bioimaging: Synthesis, Persistent luminescence and Biocompatibility

File List: Fig 1b: Size histogram of undoped gamma-Ga2O3 particles Fig 1c: DLS curve in aqueous suspension of undoped gamma-Ga2O3 particles Fig 1d : XRD pattern of undoped gamma-Ga2O3 particles Fig 1f: TG curve of undoped gamma-Ga2O3 particles Fig 2e: Particle size distributions and normal fitted curves of gamma-Ga2O3 particles doped with 0.1 %, 0.5 %, and 2.0 % Cr3+. Fig 2f: DLS curves of particles shown in (a) to (d) suspended in distilled water. Fig 3a: PLE spectrum of gamma-Ga2O3: 0.5 % Cr3+. Fig 3b: PL spectra of gamma-Ga2O3: x % Cr3+. Fig 3c: PersL decay curves of gamma-Ga2O3: x% Cr3+ after being illuminated with UV light (260 nm) for 5 min Fig 3d: PersL decay curves of gamma-Ga2O3: 2.0 % Cr3+ after being illuminated with UV light (260 nm) for 5 min recorded at two different emission wavelengths Fig 4b: FTIR spectra of the NPs@SiO2 and final NPs Fig 4c: Particle size distributions of the NPs@SiO2 and final NPs Fig 4d: DLS curves in aqueous suspension (pH 6) (d) of the NPs@SiO2 and final NPs Fig 4f: XRD pattern of the final NPs Fig 5a, 5b and 5c:Comparison of the photoluminescence properties of -Ga2O3 and gamma-Ga2O3 NPs. a) Absolute PL spectra, b) Normalized PL spectra, and c) PersL decay curves Fig 6a: PLE and PersL excitation spectra of beta-Ga2O3 NPs Fig 6b: PL and PersL emission spectra of beta-Ga2O3 NPs Fig 8a: DLS curves of beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 8b: Zavg and PdI values as a function of time, obtained from DLS measurements on beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 10: Cell viability assay of MIA PaCa-2 cell line exposed to different concentrations of beta-Ga2O3:2 % Cr3+ NPs for 24 h. Fig 11d: EDX spectrum of the region marked with a quadrangle in Fig 11b. Fig 12: Viability (a) and brood size (b) of N2 worms incubated at 20°C with different concentrations (mg·mL-1) of beta-Ga2O3:2 % Cr3+ NPs for 24h.